Literature DB >> 18648759

[Influence of environmental factors on allergy development].

W Schober1, H Behrendt.   

Abstract

The increase in allergic diseases is inter alia explained by the adjuvant effect of environmental pollutants: (1) The interaction between traffic-related airborne particles and pollen grains in the atmosphere may lead to agglomeration of particles on the surface of allergen carriers inducing their activation and to modulation of allergen release, generation of allergenic aerosols and adsorption of pollen proteins to airborne particles. (2) Anthropogenic air pollutants enhance the release of pollen-associated lipid mediators (PALMs) from pollen grains, substances with proinflammatory and immune modulating effects, which can lead to enhancement of allergic symptoms and maintenance of disease. (3) Air pollutants, such as NO(2), ozone, secondhand tobacco smoke, fine and ultrafine particles play an important role as adjuvants and trigger factors for allergic disease development as well as for elicitation and aggravation of allergic symptoms. (4) Polymorphisms in phase II drug-metabolizing enzymes can modulate susceptibility to the adjuvant effects of anthropogenic air pollutants on the IgE-mediated immune response. This highlights gene-environment interactions, which play an important role in the manifestation of allergic diseases.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18648759     DOI: 10.1007/s00106-008-1728-8

Source DB:  PubMed          Journal:  HNO        ISSN: 0017-6192            Impact factor:   1.284


  59 in total

1.  Timothy grass (Phleum pratense L.) pollen as allergen carriers and initiators of an allergic response.

Authors:  H Behrendt; J Tomczok; W Sliwa-Tomczok; A Kasche; C Ebner von Eschenbach; W M Becker; J Ring
Journal:  Int Arch Allergy Immunol       Date:  1999 Feb-Apr       Impact factor: 2.749

2.  A globally coherent fingerprint of climate change impacts across natural systems.

Authors:  Camille Parmesan; Gary Yohe
Journal:  Nature       Date:  2003-01-02       Impact factor: 49.962

3.  Combined nasal challenge with diesel exhaust particles and allergen induces In vivo IgE isotype switching.

Authors:  S Fujieda; D Diaz-Sanchez; A Saxon
Journal:  Am J Respir Cell Mol Biol       Date:  1998-09       Impact factor: 6.914

Review 4.  Intervention and policy issues related to children's exposure to environmental tobacco smoke.

Authors:  K M Emmons; M Wong; S K Hammond; W F Velicer; J L Fava; A D Monroe; J L Evans
Journal:  Prev Med       Date:  2001-04       Impact factor: 4.018

5.  Measurement of allergen concentration in the air as an aid in controlling exposure to aeroallergens.

Authors:  C E Reed; M C Swanson; J W Yunginger
Journal:  J Allergy Clin Immunol       Date:  1986-11       Impact factor: 10.793

6.  Glutathione s-transferases M1 and P1 prevent aggravation of allergic responses by secondhand smoke.

Authors:  Frank D Gilliland; Yu-Fen Li; Henry Gong; David Diaz-Sanchez
Journal:  Am J Respir Crit Care Med       Date:  2006-10-05       Impact factor: 21.405

7.  Role of free radicals in the toxicity of airborne fine particulate matter.

Authors:  B Dellinger; W A Pryor; R Cueto; G L Squadrito; V Hegde; W A Deutsch
Journal:  Chem Res Toxicol       Date:  2001-10       Impact factor: 3.739

8.  Effect of diesel exhaust particles and their components on the allergen-specific IgE and IgG1 response in mice.

Authors:  Y Heo; A Saxon; O Hankinson
Journal:  Toxicology       Date:  2001-02-28       Impact factor: 4.221

Review 9.  Health effects of air pollution.

Authors:  Jonathan A Bernstein; Neil Alexis; Charles Barnes; I Leonard Bernstein; Jonathan A Bernstein; Andre Nel; David Peden; David Diaz-Sanchez; Susan M Tarlo; P Brock Williams
Journal:  J Allergy Clin Immunol       Date:  2004-11       Impact factor: 10.793

10.  The organic component of diesel exhaust particles and phenanthrene, a major polyaromatic hydrocarbon constituent, enhances IgE production by IgE-secreting EBV-transformed human B cells in vitro.

Authors:  A Tsien; D Diaz-Sanchez; J Ma; A Saxon
Journal:  Toxicol Appl Pharmacol       Date:  1997-02       Impact factor: 4.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.